NeurologyLive: Practice-Changing News for Clinicians Treating Neurological Disease
NeurologyLive is a multimedia news platform for health care professionals who treat neurological diseases, published by MJH Life Sciences from Cranbury, New Jersey. Its mission, stated consistently across its own descriptions, is to deliver direct access to practice-changing news and expert insights from top medical conferences and researchers, in order to improve the lives of patients with neurological disease. The platform serves neurologists and the wider neuroscience care team — the physicians, nurses and other clinicians who diagnose and manage conditions of the brain, spinal cord, nerves and muscles. At neurologylive.com it combines breaking news on drug approvals and clinical trials, in-depth conference coverage, video interviews with leading experts, print journal content and disease-specific resource centers. In a specialty undergoing rapid therapeutic change, NeurologyLive positions itself as the daily briefing service that keeps busy clinicians current without requiring them to read every journal and attend every meeting themselves.
The Clinical Territory: Eight Disease Areas
NeurologyLive organizes its coverage around the major disease areas of modern neurology. Its standard description lists dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke, and its video channel presents matching condition centers for dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular conditions, sleep medicine and stroke. That list is a fair map of a contemporary neurology practice. It includes chronic progressive diseases such as Alzheimer disease, Parkinson disease and other movement disorders and multiple sclerosis; episodic conditions such as epilepsy, migraine and sleep disorders; emergencies such as stroke; and the neuromuscular diseases, from myasthenia gravis to muscular dystrophies and neuropathies, that have seen striking therapeutic advances. Structuring the site by condition lets a clinician who treats mainly one population — an MS specialist, an epileptologist, a headache physician — follow a focused stream while remaining one click from the rest of the specialty.
Publisher: MJH Life Sciences, Cranbury
NeurologyLive is a brand of MJH Life Sciences, described in the platform's partnership announcements as the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels. Earlier announcements identified it as part of the Cranbury, New Jersey-based MJH Associates family of businesses, alongside brands such as OncLive and CURE magazine. The company's history traces to founder Michael J. Hennessy Sr., who entered medical publishing in 1982, launched Multimedia Healthcare in 1993 and built the Intellisphere business that became part of MJH Life Sciences; his son Michael J. Hennessy Jr. later became president and chief executive officer and led the 2019 acquisition of the UBM Life Sciences Group. NeurologyLive's own subscription page describes MJH Life Sciences as the health care engagement company behind more than 65 clinical communities across more than 30 specialties, reaching over two million professionals. NeurologyLive is the neurology community within that system.
A Multimedia Platform, in Print and Online
NeurologyLive consistently describes itself as a multimedia platform offering both print and digital media. Its announcements say the platform offers busy health care professionals an in-depth look at new treatments in development, the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insights. Its video channel description adds in-depth conference coverage, information about upcoming meetings, content from affiliated print journals and video interviews with leading physician experts. The site also operates a subscription offering promising evidence-based coverage across the field — expert interviews, event highlights and breaking news curated for health care professionals — delivered by email. This combination matters because neurology information arrives in different forms at different speeds: a regulatory approval is a news alert, a trial result needs data and expert reaction, a diagnostic controversy needs a long interview or panel, and a print journal article rewards slower reading. NeurologyLive's model is to carry all four rhythms under one brand.
Conference Coverage and Expert Access
The promise of direct access to news and insight from top medical conferences and researchers is central to the NeurologyLive identity. Neurology's major meetings — where trial results in MS, epilepsy, dementia, migraine and stroke are first unveiled — drive the specialty's news cycle, and most practicing neurologists attend only a fraction of them. A platform that reports from those meetings, interviews presenting investigators and leading clinicians on video, and organizes the results by condition center serves as the specialty's shared notebook. The expert dimension is equally deliberate: rather than summarizing research in isolation, NeurologyLive foregrounds the voices of the researchers and clinicians who produced it and who must decide how it changes practice. Its video output is substantial enough to sustain its own channel with a regular publishing cadence, and its social channels on X, LinkedIn and Facebook distribute interviews and news between site visits, meeting clinicians inside the feeds they already use.
Partnership With the Consortium of Multiple Sclerosis Centers
Multiple sclerosis has been a particular focus of NeurologyLive's partnership work. The platform has partnered with the Consortium of Multiple Sclerosis Centers, the professional organization for MS care, to present expert-driven educational webcast programs. One announced series offered nursing professionals three continuing education credits for completing a program, while a separate three-part webcast series on cannabis and multiple sclerosis, led by Allen C. Bowling, MD, PhD, of the NeuroHealth Institute and the University of Colorado, examined pharmacology, efficacy, adverse events, drug interactions, the role of the Food and Drug Administration and MS clinical trial data, with participants earning one CE credit per session. NeurologyLive and the consortium also launched a video series on updates to MRI protocol and clinical guidelines for MS. The CMSC's chief executive, June Halper, publicly praised the partnership for bringing accredited MS education to the health care community. The pattern is instructive: for its deepest disease area, the platform works directly with the specialty's own professional consortium to produce accredited, expert-led education rather than only news.
Strategic Alliance With Cleveland Clinic
Beyond disease organizations, NeurologyLive operates a Strategic Alliance Partnership program linking it with leading clinical institutions. It expanded that program with Cleveland Clinic, one of the best-known academic medical centers in the United States, in an announcement that described the platform in its classic terms: delivering practice-changing news and expert insight for clinicians treating dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep medicine and stroke. Institutional alliances of this kind serve both partners. The platform gains access to the expertise, research activity and clinical perspective of a major center's neurology programs, while the institution gains a channel through which its specialists' work reaches a national audience of practicing clinicians. Allegheny Health Network's description of its own MJH Life Sciences alignment lists NeurologyLive among the platforms through which the network raises its national profile — further evidence that health systems treat the platform as a meaningful professional channel, not merely a news website.
Covering a Specialty in Therapeutic Upheaval
NeurologyLive's own descriptions emphasize timing: it offers its in-depth look at hundreds of new treatments in development, with ever-expanding mechanisms of action, during an unprecedented time of growing demand for neurology expertise. That framing is well founded in the platform's coverage areas. Multiple sclerosis has accumulated a large armamentarium of disease-modifying therapies with differing mechanisms and risk profiles. Migraine care has been reshaped by an entirely new class of targeted preventive and acute treatments. Alzheimer disease has entered an era of disease-modifying therapy accompanied by intense debate over benefits, risks and patient selection. Epilepsy, neuromuscular disease and stroke care continue to add drugs, devices, genetic therapies and intervention techniques. Each advance multiplies the decisions a practicing neurologist must make and the evidence they must track. A news platform organized by condition, staffed to cover trials and approvals as they happen and connected to the researchers driving the change, addresses a genuine and growing professional burden — which is precisely the demand NeurologyLive says it was built to meet.
Relationship to HCPLive and the MJH Network
NeurologyLive does not operate in isolation. When MJH Life Sciences returned its general clinical platform MD Magazine to the HCPLive brand, it introduced the HCPLive Network as a collaborative system of specialty publications headlined by ContagionLive, NeurologyLive and Rare Disease Report. NeurologyLive thus serves two roles at once: a destination in its own right for neurology professionals, and a flagship specialty node in a network whose general platform, HCPLive, covers all of medicine. Editorial talent circulates within the network — HCPLive's masthead, for example, notes an editor who previously wrote for NeurologyLive and other sister platforms. For readers, the benefit is depth without fragmentation: general neurology news, disease-specific centers, accredited education and expert video all sit within one publisher's ecosystem, produced to shared standards. For the publisher, neurology demonstrates why the network model works — a specialty with enough news volume, trial activity and clinician demand to sustain a dedicated platform that a general title alone could never serve adequately.
How Clinicians Use NeurologyLive
The typical NeurologyLive reader is a practicing clinician with limited reading time and a specific patient population. The platform's design serves that reader in layers. Email subscriptions and news feeds deliver breaking developments — an approval, a trial readout, a guideline change — as they occur. Condition centers collect everything relevant to one disease in a single place for deeper browsing. Conference coverage and video interviews supply the expert interpretation that turns a data release into a practice decision, and accredited partnership programs, such as the MS webcasts produced with the Consortium of Multiple Sclerosis Centers, convert engagement into formal continuing education. Print and affiliated journal content remain part of the mix for readers who prefer them. None of this replaces the primary literature or specialty society guidelines, and the platform does not claim to; its role is the professional news layer between the journal article and the clinic, where developments are reported, contextualized and debated by the people who will apply them.
NeurologyLive Today
Today NeurologyLive continues from Cranbury, New Jersey, as MJH Life Sciences' neurology platform, in digital and print form, covering dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke. Its verified hallmarks are consistent across years of its own announcements: practice-changing news delivered directly from conferences and researchers, clinical trial results and FDA approvals tracked as they emerge, expert video and interview formats, accredited education produced with partners such as the Consortium of Multiple Sclerosis Centers, and institutional alliances with centers including Cleveland Clinic. Inside a parent company that operates dozens of clinical communities, NeurologyLive is the neurology specialist — narrower than HCPLive by design, and deeper for it. For directory readers, it represents a mature example of the modern specialty news platform: not a journal, not a society, but the daily connective tissue between a fast-moving research field and the clinicians responsible for turning its progress into patient care.
